New Division Chief of Solid Tumor Oncology Announced
June 02, 2020
On April 1, Jorge A. Garcia, MD, FACP, was named the new Division Chief of Solid Tumor Oncology and the George & Edith Richman Distinguished Scientist Chair at University Hospitals Seidman Cancer Center.
In this newly created position, Dr. Garcia will develop clinical programs and recruit and develop faculty for GU, GI, breast, lung, head/neck, and melanoma/sarcoma cancer. He will manage clinical trials and mentor junior faculty in developing winning research proposals and organizing and executing efforts for solid tumor oncology research. As an internationally recognized clinician-scientist and leader in urologic cancers, Dr. Garcia possesses outstanding leadership skills to work collaboratively with our multi-disciplinary care teams. He will represent UH Seidman Cancer Center efforts both locally and nationally to lead the solid tumor oncology program to new heights fulfilling our mission: To Heal. To Teach. To Discover.
Dr. Garcia comes to UH after spending more than 15 years at the Cleveland Clinic as a staff physician and member of the Department of Hematology/Oncology and Urology at the Taussig Cancer Institute and Glickman Urological & Kidney Institute. Dr. Garcia also served as The Kerscher Family Chair for Clinical Prostate Cancer Research and director of the advanced prostate cancer research program. Dr. Garcia was an Associate Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, and he concentrated his primary clinical and translational research activities on prostate, kidney, and bladder cancer, with a special focus on developmental therapeutics. Dr. Garcia has authored more than 250 manuscripts and book chapters. His research has been published in multiple peer-reviewed journals, including the New England Journal of Medicine, Clinical Cancer Research, Journal of Clinical Oncology, Journal of the National Cancer Institute, and Lancet Oncology.
Dr. Garcia is a Fellow of the American College of Physicians and served as a relevance reviewer for the American Board of Internal Medicine. He also served as the Chair of the Scientific Protocol Review Committee (PRMC) and, more recently, as the director of the clinical research office (CRO) at the Case Comprehensive Cancer Center. Currently, he is an active member of the Oncologic Drugs Advisory Committee (ODAC) for the FDA. Dr. Garcia also has been listed among the best doctors in Cleveland and the United States every year since 2009.
After earning his medical degree at the Colombian School of Medicine in Bogota, Colombia, Dr. Garcia completed a fellowship in cancer biology at Harvard Medical School and completed his training in internal medicine at the Albert Einstein College of Medicine in New York. He completed his fellowship in hematology and oncology and urologic oncology at the University of California San Francisco.